Artelo Biosciences Inc (ARTL)
US$ 1.33-3.62%
Price Chart
Key Statistics
Market Cap
$ 3.31M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
34.18K
52W High
$ 1.59
52W Low
$ 0.82
Dividend Yield
0.00%
Beta
1.17
Technicals
50-Day MA
0.9859
200-Day MA
1.1383
52 Week High
1.5899
52 Week Low
0.8196
About ARTL
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
Employees
6
Headquarters
Solana Beach, CA
CEO
Mr. Gregory D. Gorgas M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg